Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/08/2859012/0/en/Inozyme-Pharma-Announces-Positive-Topline-Data-from-Ongoing-Phase-1-2-Trials-of-INZ-701-in-Adults-with-ABCC6-Deficiency-PXE-and-ENPP1-Deficiency.html
https://www.globenewswire.com/news-release/2024/04/05/2858768/0/en/Inozyme-Pharma-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/04/02/2855974/0/en/Inozyme-Pharma-to-Participate-at-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/03/26/2852366/0/en/Inozyme-Pharma-to-Report-Topline-Data-from-Ongoing-Phase-1-2-Trials-of-INZ-701-in-Adults-with-ABCC6-Deficiency-and-ENPP1-Deficiency-on-April-8-2024.html
https://www.globenewswire.com//news-release/2024/03/12/2844539/0/en/Inozyme-Pharma-Reports-Full-Year-2023-Financial-Results-and-Provides-Business-Highlights.html
https://www.globenewswire.com//news-release/2024/02/26/2835122/0/en/Inozyme-Pharma-to-Participate-in-the-TD-Cowen-44th-Annual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/02/06/2824343/0/en/Inozyme-Pharma-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2023/12/05/2790912/0/en/Inozyme-Pharma-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2023/11/09/2777359/0/en/Inozyme-Pharma-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2023/11/07/2775119/0/en/Inozyme-Pharma-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Highlights.html